From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity

Mohamed H. El‐Shershaby, Adel Ghiaty, Ashraf H. Bayoumi, Ahmed A. Al‐Karmalawy, Ebtehal M. Husseiny, Mona S. El‐Zoghbi, Hamada S. Abulkhair